Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 5 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

BIIB News and Commentary

Caps

How do you think BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,002 Outperform
68 Underperform
 

All-Star Players

253 Outperform
10 Underperform
 

Wall Street

21 Outperform
1 Underperform
 

Top BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Orthonormal (93.86)
Submitted March 12, 2016

Magic Formula 3/10/2016

NetscribeBiotech (94.70)
Submitted February 19, 2007

Biogen Idec Inc, born in 2003 post the merger of Biogen and Idec Pharmaceuticals, develops, manufactures and commercializes novel therapies. With five approved products viz. Avonex, Rituxan, Tysabr, Amevive, Zevalin and several other products in… More

BIIB VS S&P 500 (SPY)

Fools bullish on BIIB are also bullish on:

Fools bearish on BIIB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar Eskilf (61.48) Submitted: 7/27/2018 12:54:15 PM : Outperform Start Price: $340.93 BIIB Score: -0.60

PC

Recs

0
Member Avatar TMFRendezvous (83.46) Submitted: 4/16/2018 6:40:04 PM : Outperform Start Price: $265.77 BIIB Score: +23.49

Biogen has fallen victim to some slower progress in their R&D/drug pipeline. Scientists are typically more patient and focused on the long term, while Wall Street tends to sell-off or sell-up Biotechs based on short-term news. (I'm fresh off watching the Valeant documentary)

Regardless, Biogen is known for their specialty drug portfolio including multiple sclerosis, cancer and newer neurology-focused pipeline which has faced some delays. This pipeline is working to create effective treatments to one of the most consequential diseases out there...Alzheimers.

Biogen's specialty-focus gives them a competitive advantage. Even if their Alzheimer's treatment doesn't work out the company has a strong base to fall back on, but if it does, it could be the next blockbuster, life changing treatment.

Recs

0
Member Avatar TurksFan (51.24) Submitted: 4/7/2018 8:43:26 AM : Outperform Start Price: $258.29 BIIB Score: +24.01

Starting my research into biotechs

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (96.95) Score: +622.39

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey 24.05 4/12/2007 Outperform 3Y $43.64 +680.91% +107.49% +573.42 1 Comment
anewday101 87.67 3/5/2007 Outperform 1Y $43.36 +685.95% +117.09% +568.87 0 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +698.48% +131.68% +566.80 1 Comment
owen1000 92.58 8/22/2006 Outperform 3Y $42.83 +695.68% +131.35% +564.33 0 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +675.40% +112.59% +562.82 0 Comment
tradersinsights 65.23 4/10/2007 Outperform 1Y $44.42 +667.20% +106.39% +560.81 1 Comment
apple1jam 81.52 3/6/2007 2/27/2008 Outperform NS $43.94 +675.58% +115.75% +559.83 0 Comment
mtung 50.08 3/8/2007 Outperform NS $44.10 +672.77% +113.05% +559.72 0 Comment
sweetpeajack 72.34 9/20/2006 Outperform 3Y $43.38 +685.59% +126.41% +559.18 0 Comment
karimod99 52.65 9/19/2006 Outperform NS $43.44 +684.51% +126.62% +557.89 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackUBS 92.21 1/31/2018 Outperform NS $357.57 -4.69% -0.22% -4.47 0 Comment
TrackGoldmanSach 76.60 7/26/2017 Outperform NS $285.02 +19.57% +13.86% +5.70 0 Comment
TrackStandpoint 35.90 1/7/2016 Outperform 5Y $286.15 +15.14% +10.49% +4.64 8/2/2016 @ $329.47 0 Comment
TrackJPMorgan 87.17 5/29/2014 Outperform NS $314.86 +8.24% +47.06% -38.83 0 Comment
TrackBMOCapital < 20 3/6/2014 Outperform NS $346.36 -1.61% +49.89% -51.49 0 Comment
TrackPiperJaff 85.51 11/27/2013 Outperform NS $292.80 +16.39% +55.97% -39.58 0 Comment
TrackCitigroup 91.90 6/28/2013 Outperform NS $222.58 +53.11% +75.62% -22.51 0 Comment
TrackCreditSuiss 88.98 6/14/2013 Outperform NS $212.00 +60.75% +71.98% -11.23 0 Comment
TrackZacks < 20 10/19/2012 Underperform 3M $33.33 +318.86% -3.40% -322.26 11/12/2012 @ $139.61 1 Comment
TrackZacks < 20 7/6/2012 Outperform 3M $142.46 +2.24% +5.83% -3.59 10/19/2012 @ $145.65 1 Comment
TrackStifel 92.28 3/15/2012 Outperform NS $120.50 +182.81% +101.33% +81.49 0 Comment
TrackZacks < 20 1/24/2012 Outperform 3M $117.03 -0.38% -0.07% -0.32 1/30/2012 @ $116.58 1 Comment
TrackJimCramer 85.55 1/10/2012 Outperform 3W $114.88 +196.65% +118.46% +78.19 0 Comment
TrackBarclaysCap 89.07 12/9/2011 Outperform NS $113.02 +201.53% +124.03% +77.50 0 Comment
TrackUBS 92.21 9/9/2011 Outperform NS $91.61 +65.55% +22.13% +43.42 9/10/2012 @ $151.66 0 Comment
TrackOppenheimer 74.50 8/18/2011 Outperform NS $88.45 +72.76% +24.83% +47.93 10/8/2012 @ $152.81 0 Comment
TrackDeutscheSec 87.12 6/21/2011 Outperform NS $98.72 +245.21% +117.63% +127.58 0 Comment
TrackMPAdvisors < 20 4/15/2011 Outperform NS $82.43 +52.89% +4.42% +48.48 4/17/2012 @ $126.03 0 Comment
TrackRBCCapMkts 87.33 2/24/2011 Outperform NS $67.23 +406.90% +115.54% +291.36 0 Comment
TrackOppenheimer 74.50 2/2/2011 Underperform NS $65.28 +35.49% -11.30% -46.80 8/18/2011 @ $88.45 0 Comment
TrackGoldmanSach 76.60 11/5/2010 Underperform 5Y $62.49 +373.18% +102.27% -270.91 7/26/2017 @ $295.69 1 Comment
TrackStifel 92.28 9/9/2010 Underperform NS $57.23 +110.55% +25.29% -85.26 3/15/2012 @ $120.50 0 Comment
TrackZacks < 20 8/19/2010 Outperform 3M $55.06 +6.70% +10.49% -3.78 10/22/2010 @ $58.75 1 Comment
TrackSoleil 96.63 3/9/2010 Outperform NS $57.64 +491.24% +147.61% +343.63 0 Comment
TrackStandpoint 35.90 1/19/2010 Outperform NS $54.29 +15.78% +4.22% +11.56 10/28/2010 @ $62.86 0 Comment
TrackJefferies 79.81 11/3/2009 Outperform NS $42.86 +695.12% +170.91% +524.21 0 Comment
TrackBMOCapital < 20 10/21/2009 Underperform NS $46.95 +638.91% +70.90% -568.02 3/6/2014 @ $346.92 0 Comment
TrackLeerinkSwan 96.99 7/14/2009 Outperform NS $46.62 +631.00% +213.61% +417.38 0 Comment
TrackBarclaysCap 89.07 2/9/2009 Underperform NS $51.28 -0.06% +5.97% +6.03 5/20/2009 @ $51.25 0 Comment
TrackBreanMurray 75.41 1/28/2009 Underperform NS $49.10 +594.07% +232.28% -361.79 0 Comment
TrackCanaccord 66.10 12/12/2008 Outperform NS $46.31 +635.89% +230.50% +405.39 0 Comment
TrackRWBaird 88.83 11/3/2008 Outperform NS $44.26 +18.17% -10.72% +28.88 2/6/2009 @ $52.30 0 Comment
TrackCowenandCo 79.58 10/28/2008 Outperform NS $41.88 +713.73% +229.59% +484.14 0 Comment
TrackZacks < 20 10/13/2008 Outperform 3M $47.13 +8.23% +13.13% -4.90 9/5/2009 @ $51.01 1 Comment
TrackLazardCapit 79.63 9/25/2008 Outperform NS $48.24 +606.45% +142.18% +464.26 0 Comment
TrackStanfordRes < 20 9/11/2008 Outperform NS $46.55 +170.74% +13.06% +157.68 4/17/2012 @ $126.03 0 Comment
TrackDodgeCox 92.95 3/31/2008 Outperform NS $61.69 -15.92% -37.13% +21.21 2/5/2009 @ $51.87 1 Comment
TrackBofASec 92.35 1/17/2008 Outperform NS $60.61 +462.27% +113.34% +348.93 0 Comment
TrackBWS 96.65 1/15/2008 Outperform NS $59.11 -7.97% -13.88% +5.91 4/20/2010 @ $54.40 0 Comment
TrackJimCramer 85.55 11/27/2007 Underperform 3W $69.75 +64.70% -9.43% -74.13 1/11/2012 @ $114.88 0 Comment
TrackZacks < 20 10/24/2007 Underperform 3M $76.72 -27.57% -4.23% +23.34 12/17/2007 @ $55.57 1 Comment
TrackPiperJaff 85.51 10/16/2007 Underperform NS $81.05 -32.62% -4.44% +28.19 12/13/2007 @ $54.61 0 Comment
TrackBWS 96.65 10/16/2007 Underperform NS $81.05 -13.86% -5.69% +8.17 11/13/2007 @ $69.82 0 Comment
TrackDeutscheSec 87.12 10/15/2007 Outperform NS $81.85 -41.56% -40.46% -1.11 6/29/2009 @ $47.83 0 Comment
TrackCreditSuiss 88.98 10/2/2007 Underperform NS $67.11 -17.87% -3.94% +13.93 12/13/2007 @ $55.12 0 Comment
TrackEdwardOwens 99.14 9/30/2007 Outperform NS $66.33 +413.78% +93.71% +320.07 5 Comments
TrackIcahn 89.18 9/30/2007 Outperform NS $66.33 +413.78% +93.71% +320.07 4 Comments
TrackEveillard 94.57 9/30/2007 Outperform NS $66.33 -14.19% -4.17% -10.01 12/31/2007 @ $56.92 1 Comment
TrackUBS 92.21 9/13/2007 Underperform NS $63.54 -33.00% -36.85% -3.84 10/29/2008 @ $42.57 0 Comment
TrackBWS 96.65 3/6/2007 Outperform NS $43.94 +46.97% +6.30% +40.68 8/31/2007 @ $64.58 0 Comment
TrackLehmanBros < 20 11/20/2006 Outperform NS $51.09 +1.12% +7.13% -6.01 6/26/2007 @ $51.66 0 Comment
TrackJimCramer 85.55 3/2/2006 Outperform 3W $46.36 +50.45% +10.79% +39.67 11/27/2007 @ $69.75 0 Comment

Featured Broker Partners


Advertisement